Status:
RECRUITING
Evaluation of Hemostasis in Bleeding and Thrombotic Disorders
Lead Sponsor:
The University of Texas Health Science Center, Houston
Conditions:
Blood Coagulation Disorders, Inherited
Thrombotic Disorder
Eligibility:
All Genders
1-98 years
Brief Summary
The objective of this study will be to assess the coagulation system in-vitro in a variety of bleeding and clotting disorders using the ROTEG analyzer and the thrombin generation assay.
Detailed Description
This is an exploratory study involving blood coagulation assays in a select group of individuals receiving treatment for their congenital or acquired bleeding or clotting disorder at UTHealth Houston....
Eligibility Criteria
Inclusion
- patients with congenital or acquired bleeding or clotting disorders who have provided informed consent and/or assent
Exclusion
- poor venous access
Key Trial Info
Start Date :
October 1 2002
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2028
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT00178594
Start Date
October 1 2002
End Date
January 1 2028
Last Update
January 9 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
The Univerisity of Texas Health Science Center at Houston
Houston, Texas, United States, 77030
2
UT Physicians Women's Center-Texas Medical Center
Houston, Texas, United States, 77030